Plus Therapeutics (PSTV) Appoints Eric Daniels as Chief Development Officer
Published on · Source: investing.com
AI Summary
Summarized by AI from the source belowPlus Therapeutics (PSTV) announced the appointment of Eric Daniels as chief development officer. This leadership change is part of the company's strategy to advance its clinical and regulatory efforts. Eric brings extensive experience in medicine and drug development, which may improve PSTV's competitive position in the market. The appointment is expected to drive progress in Plus Therapeutics' pipeline and operational efficiency.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
